Publications - Paul A . Fredrickson, M.D.

Back to Research Profile

1. Liang Y, Boules M, Shaw AM, Williams K, Fredrickson P, Richelson E. Effect of a novel neurotensin analog, NT69L, on nicotine-induced alterations in monoamine levels in rat brain. Brain Res 2008 Sep 22; 1231:6-15. Epub 2008 Jul 19.
   View PubMed
2. Willis FB, Isley AL, Geda YE, Quarles L 4th, Fredrickson PA. Resolution of syncope with treatment of sleep apnea. J Am Board Fam Med 2008 Sep-Oct; 21(5):466-8.
   View PubMed
3. Willis FB, Isley AL, Geda YE, Quarles L 4th, Fredrickson PA. Resolution of syncope with treatment of sleep apnea. J Am Board Fam Med 2008 Sep-Oct; 21(5):466-8.
   View PubMed
4. Willis FB, Isley AL, Geda YE, Quarles L 4th, Fredrickson PA. Resolution of syncope with treatment of sleep apnea. J Am Board Fam Med 2008 Sep-Oct; 21(5):466-8.
   View PubMed
5. Willis FB, Isley AL, Geda YE, Quarles L 4th, Fredrickson PA. Resolution of syncope with treatment of sleep apnea. J Am Board Fam Med 2008 Sep-Oct; 21(5):466-8.
   View PubMed
6. Bendel RE, Kaplan J, Heckman M, Fredrickson PA, Lin SC. Prevalence of glaucoma in patients with obstructive sleep apnoea--a cross-sectional case-series. Eye (Lond) 2008 Sep; 22(9):1105-9. Epub 2007 May 04.
   View PubMed
7. Willis FB, Isley AL, Geda YE, Quarles L 4th, Fredrickson PA. Resolution of syncope with treatment of sleep apnea. J Am Board Fam Med 2008 Sep-Oct; 21(5):466-8.
   View PubMed
8. Isley A, Willis F, Geda Y, Fredrickson P. Resolution of Syncope with Treatment of Sleep Apnea. Journal of the American Board of Family Medicine 2008. Accepted for Publication.
   View PubMed
9. Bendel RE, Kaplan J, Heckman M, Fredrickson PA, Lin S-C. Prevalence of glaucoma in patients with obstructive sleep apnoea- a cross-sectional case-series. Eye advance online publication 2007 May; doi:10.1038/sj.eye.6.
   View PubMed
10. Ames SC, Patten CA, Werch CE, Schroeder DR, Stevens SR, Fredrickson PA, Echols JD, Pennebaker JW, Hurt RD. Expressive writing as a smoking cessation treatment adjunct for young adult smokers. Nicotine Tob Res 2007 Feb; 9(2):185-94.
    View PubMed
11. Boules M, Iversen I, Oliveros A, Shaw A, Williams K, Robinson J, Fredrickson P, Richelson E. The neurotensin receptor agonist NT69L suppresses sucrose-reinforced operant behavior in the rat. Brain Res 2007 Jan 5; 1127(1):90-8 Epub 2006 Nov 17.
    View PubMed
12. Ames SC, Patten CA, Werch C, Schroeder DR, Stevens SR, Fredrickson PA, Echols DJ, Pennebaker J, Hurt RD. Expressive writing as a smoking cessation treatment adjunct for young adult smokers. In press. 2007.
13. Boules M, Shaw A, Fredrickson P, Richelson E. Neurotensin agonists: potential in the treatment of schizophrenia. CNS Drugs 2007; 21(1):13-23.
    View PubMed
14. Castillo PR, Kaplan J, Lin SC, Fredrickson PA, Mahowald MW. Prevalence of restless legs syndrome among native South Americans residing in coastal and mountainous areas. Mayo Clin Proc 2006 Oct; 81(10):1345-7.
    View PubMed
15. Boules M, Fredrickson P, Richelson E. Bioactive analogs of neurotensin: focus on CNS effects. Peptides 2006 Oct; 27(10):2523-33. Epub 2006 Aug 01.
    View PubMed
16. Black JL, Silber MH, Krahn LE, Avula RK, Walker DL, Pankratz VS, Fredrickson PA, Slocumb NL. Studies of humoral immunity to preprohypocretin in human leukocyte antigen DQB1*0602-positive narcoleptic subjects with cataplexy. Biol Psychiatry 2005 Sep 15; 58(6):504-9.
    View PubMed
17. Fredrickson P, Boules M, Lin SC, Richelson E. Neurobiologic basis of nicotine addiction and psychostimulant abuse: a role for neurotensin? Psychiatr Clin North Am 2005 Sep; 28(3):737-51, 746.
    View PubMed
18. Black JL 3rd, Silber MH, Krahn LE, Fredrickson PA, Pankratz VS, Avula R, Walker DL, Slocumb NL. Analysis of hypocretin (orexin) antibodies in patients with narcolepsy. Sleep 2005 Apr 1; 28(4):427-31.
    View PubMed
19. Boules M, Fredrickson P, Richelson E. Neurotensin agonists as an alternative to antipsychotics. Expert Opin Investig Drugs 2005 Apr; 14(4):359-69.
    View PubMed
20. Boues M, Fredrickson P, Richelson E. Current topics: brain penetrating neurotensin analog. Life Sci 2003 Oct 17; 73(22):2785-92.
    View PubMed
21. Fredrickson P, Boules M, Yerbury S, Richelson, E. Novel neurotensin analog blocks the initiation and expression of nicotine-induced sensitization in rats. Brain Res 2003 Jul 25; 979(1-2):245-8.
    View PubMed
22. Fredrickson P, Boules M, Yerbury S, Richelson E. Novel neurotensin analog blocks the initiation and expression of nicotine-induced locomotor sensitization. Brain Res 2003 Jul 25; 979(1-2):245-8.
    View PubMed
23. Richelson E, Boules M, Fredrickson P. Neurotensin agonists: possible drugs for treatment of psychostimulant abuse. Life Sci 2003 Jun 27; 73(6):679-90.
    View PubMed
24. Fredrickson P, Boules M, Yerbury S, Richelson E. Blockade of nicotine-induced locomotor sensitization by a novel neurotensin analog in rats. Eur J Pharmacol 2003 Jan 1; 458(1-2):111-8.
    View PubMed
25. Becker PM, Jamieson AO, Jewel CE, Bogan RK, James DS, Sutton JT, Corser B, Mayleben DW, Bernard SH, Dinner DS, Emsellem H, Knight E, Erwin CW, Krystal AD, Radtke RA, Farrow S, Odynski T, Pinto J, Steljes D, Feldman NT, O'Brien M, Fredrickson PA, Kaplan J, Randomized trial of modafinil as a treatment for the excessive daytime somnolence of narcolepsy. Neurology 2000 Mar 14; 54(5):1166-1175.
    View PubMed
26. Dinges D, Ball E, Fredrickson P, Kiley J, Kryger MH, Richardson GS, Rogus S, Sheldon S, Wooten V, Zepf B. Recognizing problem sleepiness in your patients. Am Fam Physician 1999 Feb 15; 59(4):937-944.
    View PubMed
27. Lin SC, Kaplan J, Burger CD, Fredrickson PA. Effect of pramipexole in treatment of resistant restless legs syndrome. Mayo Clin Proc 1998 Jun; 73(6):497-500.
    View PubMed
28. Mitler MM, Guilleminault C, Harsh JR, Hirshkowitz M, Fredrickson PA, Kaplan J. U.S. Modafinil in Narcolepsy Study Group. Randomized trial of modafinil for the treatment of pathological somnolence in narcolepsy. Annals of Neurology 43:88-97, 1998.
29. Fredrickson PA, Hurt RD, Lee GM, Wingender L, Croghan IT, Lauger G, Gomez-Dahl L, Offord KP. High dose transdermal nicotine therapy for heavy smokers: safety, tolerability and measurement of nicotine and cotinine levels. Psychopharmacology (Berl) 1995 Dec; 122(3):215-22.
    View PubMed
30. Loui WS, Blackshear JL, Fredrickson PA, Kaplan J. Obstructive sleep apnea manifesting as suspected angina: report of three cases. Mayo Clin Proc 1994 Mar; 69(3):244-8.
    View PubMed
31. Hurt RD, Dale LC, Fredrickson PA, Caldwell CC, Lee GA, Offord K, Lauger GG, Marusic Z, Neese LW, Lundberg TG. Nicotine patch therapy for smoking cessation combined physician advice and nurse follow-up: one year outcome and percentage of nicotine replacement. JAMA 1994 Feb 23; 271:595-600.
    View PubMed
32. Kaplan J, Fredrickson PA, Renaux SA, O'Brien PC. Theophylline effect on sleep in normal subjects. Chest 1993 Jan; 103(1):193-5.
    View PubMed
33. Juergens SM, Hurt RD, Offord KP, Zarling KK, Zemke KK, Anderson LL, Fredrickson PA, Miller FA. Alcoholism in a coronary care population. J Addict Dis 1993; 12(2):57-76.
    View PubMed
34. Mahowald M, Ferber R, Fredrickson P, Perez-Guerra F, Reite M, Smith P, Thorpy M, Westbrook P. Assessment: Techniques associated with the diagnosis and management of sleep disorders. Neurology 1992; 42:269-74.
    View PubMed
35. Thorpy M, Westbrook P, Ferber R, Fredrickson P, Mahowald M, Perez-Guerra F, Reite M, Smith P. The clinical use of the multiple sleep latency test. Sleep 1992; 15(3):268-76.
    View PubMed
36. Fredrickson P. Insomnia in primary care medicine. Position paper prepared for the National Commission on Sleep Disorders Research, Wake Up America: A National Sleep Alert-Report of the National Commission on Sleep Disorders Research, Department of Health and Human Services, Washington, D.C.: Superintende nt of Documents, U.S. Government Printing Office,1992.
37. Kaplan J, Fredrickson PA, Richardson JW. Sleep and breathing in patients with the Prader-Willi syndrome. Mayo Clin Proc 1991 Nov; 66(11):1124-6.
    View PubMed
38. Richardson JW, Fredrickson PA, Lin SC. Narcolepsy update. Mayo Clin Proc 1990 Jul; 65(7):991-8.
    View PubMed
39. Fredrickson PA, Richardson JW, Esther MS, Lin SC. Sleep disorders in psychiatric practice. Mayo Clin Proc 1990 Jun; 65(6):861-8.
    View PubMed
40. Fredrickson PA, Kaplan J, Richardson JW, et al. Prevalence of alcohol abuse in narcolepsy and other disorders of excessive somnolence. Archives of the Foundation of Thanatology 1989; 16:113-4.
41. Fredrickson PA. The relevance of sleep disorders medicine to psychiatric practice. Psychiatr Ann 1987 Feb; 17:91-5, 99-100.
42. Juergens SM, Fredrickson PA, Pfeiffer FE. Balint's syndrome mistaken for visual conversion reaction. Psychosomatics 1986 Aug; 27(8):597-9.
    View PubMed
43. Flavin DK, Fredrickson PA, Richardson JW, Merritt TC. Corticosteroid abuse--an unusual manifestation of drug dependence. Mayo Clin Proc 1983 Nov; 58(11):764-6.
    View PubMed
44. Fredrickson P, Richelson E. Mayo Seminars in Psychiatry: dopamine and schizophrenia--a review. J Clin Psychiatry 1979 Sep; 40(9):399-405.
    View PubMed
45. Fredrickson PA, Richelson E. Hallucinogens antagonize histamine H1 receptors of cultured mouse neuroblastoma cells. Eur J Pharmacol 1979 Jun 15; 56(3):261-4.
    View PubMed
46. Ames SC, Pattern CA, Werch CE, Stevens SR, Frederickson PA, Echols JD, Pennebaker JW, Hutt RD. Expressive writing as a smoking cessation treatment adjunct for young adult smokers. Nicotine and Tobacco Research 2007 Feb; 2(2):185-94.
    View PubMed